Dassault Systèmes has invested in Click Therapeutics to enhance the patient experience in healthcare through integrated digital therapeutic solutions.
Information on the Target
Click Therapeutics is at the forefront of the prescription digital therapeutics sector, setting benchmarks for software-enhanced drug therapies. The company specializes in developing evidence-based digital therapies that are designed to treat serious medical conditions, supporting pharmaceutical companies in enhancing the patient's treatment journey.
By leveraging digital advancements and vast data analytics, Click Therapeutics aims to bridge the gap between traditional medical treatments and innovative digital solutions. This position allows them to influence patient care positively and streamline the integration of technology within healthcare practices.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
The digital therapeutics industry has experienced significant growth in recent years, particularly in the United States. As healthcare increasingly shifts towards personalized medicine,
Similar Deals
Walgreens Boots Alliance, Inc. → Cencora, Inc.
2025
Danaher Corporation → Innovaccer Inc.
2025
NAMSA → WuXi AppTec's U.S. medical device testing operations
2025
Gentex Corporation → eSight
2024
Edwards Lifesciences → Innovalve Bio Medical Ltd.
2024
Dassault Systèmes
invested in
Click Therapeutics
in 2025
in a Other Corporate deal